Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Sophie G. Carter"'
Autor:
Isabella Epiu, Simon C. Gandevia, Claire L. Boswell‐Ruys, Sophie G. Carter, Harrison T. Finn, David A. T. Nguyen, Jane E. Butler, Anna L. Hudson
Publikováno v:
Physiological Reports, Vol 10, Iss 23, Pp n/a-n/a (2022)
Abstract Altered neural processing and increased respiratory sensations have been reported in chronic obstructive pulmonary disease (COPD) as larger respiratory‐related evoked potentials (RREPs), but the effect of healthy‐aging has not been consi
Externí odkaz:
https://doaj.org/article/bbca4702b3794f05880bfad4bae473e5
Autor:
Alan Chiang, Sophie G. Carter, Robert J. Adams, Andrew Vakulin, Ludovico Messineo, Danny J. Eckert, Luigi Taranto-Montemurro, Jayne C. Carberry
Publikováno v:
Respirology. 26:878-886
Background and objective Atomoxetine combined with oxybutynin (Ato-Oxy) has recently been shown to reduce obstructive sleep apnoea (OSA) severity by >60%. However, Ato-Oxy also modestly reduced the respiratory arousal threshold, which may decrease sl
Autor:
Sophie G. Carter, Danny J. Eckert
Publikováno v:
Sleep medicine reviews. 58
Impaired upper airway anatomy is the main cause of obstructive sleep apnea (OSA). However, there are other important non-anatomical contributors or "endotypes" including ventilatory control instability, poor pharyngeal dilator muscle responsiveness a
Autor:
Simon C. Gandevia, J. Patti, F. Knapman, Lynne E. Bilston, Sophie G. Carter, Jane E. Butler, Danny J. Eckert, M. Butlin, Peter G R Burke
Publikováno v:
D29. SRN: NOVEL THERAPEUTIC APPROACHES TOWARDS SDB: CAN PATHOPHYSIOLOGY LEND A HELPING HAND?.
Zolpidem Increases Sleep Efficiency and the Respiratory Arousal Threshold in Obstructive Sleep Apnea
Publikováno v:
D29. SRN: NOVEL THERAPEUTIC APPROACHES TOWARDS SDB: CAN PATHOPHYSIOLOGY LEND A HELPING HAND?.
Publikováno v:
Nature and Science of Sleep
The prevalence of obstructive sleep apnea (OSA) continues to rise. So too do the health, safety, and economic consequences. On an individual level, the causes and consequences of OSA can vary substantially between patients. In recent years, four key
Autor:
Rodrigo Tomazini Martins, Jayne C. Carberry, Sophie G. Carter, Amal M Osman, CP Rollo, Benjamin Tong, Danny J. Eckert
Publikováno v:
Journal of Sleep Research. 28
Publikováno v:
Chest. 158(1)
Background Studies indicate that standard doses of hypnotics reduce or do not change the apnea-hypopnea index (AHI) or pharyngeal muscle activity. A 1-month trial of nightly zopiclone (7.5 mg) modestly reduced the AHI vs baseline without changing oth
Autor:
Rodrigo Tomazini Martins, Lynne E. Bilston, Ronald R. Grunstein, Danny J. Eckert, Michael S. Berger, Sophie G. Carter, Benjamin K. Y. Tong, Jane E. Butler, Jayne C. Carberry, David K. McKenzie, Lauren P. Fisher
Publikováno v:
Sleep. 39:757-766
Study objectives To determine the effects of the nonbenzodiazepine sedative zopiclone on the threshold to arousal with increasing respiratory effort and genioglossus muscle activity and to examine potential physiological factors mediating disparate e
Publikováno v:
Journal of sleep researchREFERENCES. 28(5)
Pharyngeal and oesophageal manometry is used clinically and in research to quantify respiratory effort, upper-airway mechanics and the pathophysiological contributors to obstructive sleep apnea. However, the effects of this equipment on respiratory e